Economic Burden of Chronic Migraine in OECD countries: A Systematic Review

Author:

Eltrafi Alyaa1,Shrestha Sunil2,Ahmed Ali2,Mistry Hema3,Paudyal Vibhu1,Khanal Saval3ORCID

Affiliation:

1. University of Birmingham Barnes Medical Library: University of Birmingham College of Medical and Dental Sciences

2. Monash University Malaysia

3. University of Warwick Warwick Medical School

Abstract

Abstract Background Chronic migraine (CM) is a headache disorder leading cause of disability worldwide. The condition is diagnosed when patients experience at least 15 headache days per month for at least three months. Due to the severe nature of CM, the illness is associated with a significant social, physical, and financial burden. Determining the costly components and overall economic burden of CM can help guide health policy decision-making. Thus, the objective of this systematic review is to summarise the economic burden of chronic migraines in Organisation for Economic Co-operation and Development (OECD) countries and analyze the methodology and findings of chronic migraine cost of illness studies Methods Databases (including MEDLINE, Embase and CINAHL) were searched with a broad search strategy for studies that estimated the cost of illness of chronic migraines. The articles were limited to the English Language, from inception to October 2021 and only findings from OECD countries. Methodology features and key findings were extracted from the studies. The costs stated by the articles were converted to GBP to allow comparisons. Results The search identified thirteen eligible cost-of-illness studies conducted in OECD countries. The findings exhibited considerable direct and indirect costs associated with chronic migraine. The direct costs for chronic migraine ranged from GBP 1,754.52 to GBP 8,219.46 annually per person. In addition, hospitalisation and drugs cost was revealed to be profoundly burdensome direct healthcare cost. Whereas indirect costs ranged from £2579.07 to £48,810, and the total annual cost ranged from £6,443.41 to 53,446.38. Conclusion CM has a substantially high cost of illness across multiple OECD countries. However, there is a lack of research estimating the cost of illness. Current research is also limited to a low number of OECD countries. In addition, indirect costs are infrequently considered. Thus, there is an opportunity for further research in this area.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3